Get started
Author

Kazuyuki Numakura

Observed names: K Numakura, K. Numakura, K.N Numakura, K.N. Numakura, KAZUYUKI NUMAKURA, Numakura, Kazuyuki, 沼倉 一幸
Observed institutions: Yamagata University, Brigham and Women's Hospital, Kyushu University, Harvard University, Asahikawa Medical University, Akita University, Charles University, University Medical Center Hamburg-Eppendorf, Akita University Hospital, Thomayer University Hospital, Iwate Prefectural Isawa Hospital, Asahikawa University
ORCID: 0000-0002-5899-1738
Observed ORCID: 0000-0002-5899-1738
OpenAlex ID: A5023422160
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2022 · Thomas Powles, Piotr Tomczak, et al. · The Lancet Oncology · 320
PDF
Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer
2012 · Shintaro Narita, Norihiko Tsuchiya, et al. · World Journal of Surgical Oncology · 102
PDF
Clinical and Genetic Risk Factors for Posttransplant Diabetes Mellitus in Adult Renal Transplant Recipients Treated with Tacrolimus
2005 · Kazuyuki Numakura, Shigeru Satoh, et al. · Transplantation · 96
Impact of the CYP3A4*1G Polymorphism and its Combination with CYP3A5 Genotypes on Tacrolimus Pharmacokinetics in Renal Transplant Patients
2011 · Masatomo Miura, Shigeru Satoh, et al. · Pharmacogenomics · 79
A high‐fat diet enhances proliferation of prostate cancer cells and activates MCP‐1/CCR2 signaling
2012 · Mingguo Huang, Shintaro Narita, et al. · The Prostate · 70
Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome
2011 · Mingguo Huang, Shintaro Narita, et al. · Carcinogenesis · 62
Comparison of Pharmacokinetics and Pharmacogenetics of Once- and Twice-Daily Tacrolimus in the Early Stage After Renal Transplantation
2012 · Takenori Niioka, Shigeru Satoh, et al. · Transplantation · 61
Fatty acid binding protein 4 enhances prostate cancer progression by upregulating matrix metalloproteinases and stromal cell cytokine production
2017 · Mingguo Huang, Shintaro Narita, et al. · Oncotarget · 52
Circadian Pharmacokinetics of Mycophenolic Acid and Implication of Genetic Polymorphisms for Early Clinical Events in Renal Transplant Recipients
2006 · Shigeru Satoh, Hitoshi Tada, et al. · Transplantation · 49
Genomic profiling of renal cell carcinoma in patients with end‐stage renal disease
2011 · Toru Inoue, Keiko Matsuura, et al. · Cancer Science · 48
PDF
Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101
2019 · Motohide Uemura, Yoshihiko Tomita, et al. · Cancer Science · 44
PDF
The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the “obesity paradox”
2017 · Ryuichi Ito, Shintaro Narita, et al. · PLoS ONE · 43
PDF
Hyperuricemia at 1 Year After Renal Transplantation, Its Prevalence, Associated Factors, and Graft Survival
2012 · Kazuyuki Numakura, Shigeru Satoh, et al. · Transplantation · 43
Diet-induced alteration of fatty acid synthase in prostate cancer progression
2016 · M Huang, A Koizumi, et al. · Oncogenesis · 39
PDF
Correlations Between Pretransplant Dialysis Duration, Bladder Capacity, and Prevalence of Vesicoureteral Reflux to the Graft
2011 · Takamitsu Inoue, Shigeru Satoh, et al. · Transplantation · 39
Incidence and location of positive surgical margin among open, laparoscopic and robot-assisted radical prostatectomy in prostate cancer patients: a single institutional analysis
2018 · Atsushi Koizumi, Shintaro Narita, et al. · Japanese Journal of Clinical Oncology · 38
Lack of tacrolimus circadian pharmacokinetics and CYP3A5 pharmacogenetics in the early and maintenance stages in Japanese renal transplant recipients
2008 · Shigeru Satoh, Hideaki Kagaya, et al. · British Journal of Clinical Pharmacology · 38
PDF
Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival
2014 · Sohei Kanda, Norihiko Tsuchiya, et al. · International Journal of Cancer · 35
Macrophage inhibitory cytokine‐1 induced by a high‐fat diet promotes prostate cancer progression by stimulating tumor‐promoting cytokine production from tumor stromal cells
2021 · Mingguo Huang, Shintaro Narita, et al. · 癌症：英文版 · 34
Pharmaceutical and genetic determinants for interindividual differences of tacrolimus bioavailability in renal transplant recipients
2013 · Takenori Niioka, Hideaki Kagaya, et al. · European Journal of Clinical Pharmacology · 33
The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer
2023 · Kazuyuki Numakura, Mizuki Kobayashi, et al. · Current Oncology · 30
PDF
Severe Immune-Related Adverse Events in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma Are Associated with PDCD1 Polymorphism
2022 · Mizuki Kobayashi, Kazuyuki Numakura, et al. · Genes · 30
PDF
Non-maintenance intravesical Bacillus Calmette–Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study
2021 · on behalf of the Japanese Urological Oncology Group, Makito Miyake, et al. · BMC Cancer · 30
PDF
Cytotoxic T Lymphocytes Regenerated from iPS Cells Have Therapeutic Efficacy in a Patient-Derived Xenograft Solid Tumor Model
2020 · Soki Kashima, Takuya Maeda, et al. · iScience · 30
PDF
Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer
2020 · Yoshinori Matsuda, Shintaro Narita, et al. · BMC Cancer · 29
PDF
Works count: 341
Citation count: 2,882
H-index: 28
I10-index: 85
Year
Topic
Type